0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences

Buy Now

Excitotoxicity in Neurological Diseases - New Therapeutic Challenge (Paperback, Softcover reprint of the original 1st ed. 2004) Loot Price: R4,253
Discovery Miles 42 530
Excitotoxicity in Neurological Diseases - New Therapeutic Challenge (Paperback, Softcover reprint of the original 1st ed....

Excitotoxicity in Neurological Diseases - New Therapeutic Challenge (Paperback, Softcover reprint of the original 1st ed. 2004)

Carlo Ferrarese, M.Flint Beal

 (sign in to rate)
Loot Price R4,253 Discovery Miles 42 530 | Repayment Terms: R399 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

It can be reasonably anticipated that, over the next generations, the proportion of elderly people will remarkably increase and, with this, the number ofpersons suffering from acute (e.g. cerebral ischemia) or chronic neurodegenerative disorders. To date, approved drugs only alleviate the symptoms ofthese diseases (for instance, acetylcholinesterase inhibitors in Alzheimer disease and L-dopa and dopamine-agonists in Parkinson disease), while none seems to stop the progression of the degenerative processes underlying them. The development of effective preventive or protective therapies has been impeded by the limitations of our knowledge of the causes and the mechanisms by which neurons die in neurodegenerative disorders. Evidence accumulated in the past 20 years indicated that the major excitatory neurotransmitter glutamate may play a role as neurotoxin in several conditions. In particular, the glutamatergic system dysfunction seems to be an early event working as a common pathway in the pathogenesis ofa large number ofacute and chronic neurological disorders, in strict conjunction with other important mechanisms, such as oxidative stress and energetic failure, and probably triggered by different mechanisms in various diseases. In consideration of that, drug discovery efforts over the last decade have been focused on the search for drugs that either reduce glutamate synaptic levels or block its postsynaptic effects. Despite numerous reviews on basic mechanisms and clinical aspects ofthe excitotoxic phenomenon, so far no comprehensive book has covered the topic in all its complexity, starting from basic pharmacological mechanisms, to .animal models of diseases and finally to clinical pathogenic and therapeutic implications.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Release date: March 2013
First published: 2004
Editors: Carlo Ferrarese • M.Flint Beal
Dimensions: 235 x 155 x 19mm (L x W x T)
Format: Paperback
Pages: 362
Edition: Softcover reprint of the original 1st ed. 2004
ISBN-13: 978-1-4613-4736-1
Categories: Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology
Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences
LSN: 1-4613-4736-X
Barcode: 9781461347361

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners